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The production of mAbs of various isotypes to Schistosoma mansoni has greatly
contributed to the appreciation of the function of antibodies in the immunity
against schistosomiasis, and has allowed the characterization of several potential
protective antigens . Using this approach, we clearly established in previous
studies (1, 2) the close relationship existing between a 38,000M r S . mansoni
schistosomulum surface antigenand theexpression of eosinophil-mediated killing
of schistosomula . The 38,000 M,. antigen was initially characterized by the
IPLSm 1 rat IgG2amAb that exhibits a marked eosinophil-dependent cytotoxicity
and passively transfers a high degree of protection towards a cercarial challenge
(1, 2) . This particular surface antigen was also shown to react with polyclonal
antibodies present in various infected hosts including mice, rats, monkeys, and
humans (3) . Additional studies revealed that 97% of a group of 120 Brazilian
patients with S . mansoni infection produced circulating antibodies against this
antigen, suggesting that the 38,000Mi molecule corresponds to a potent immu-
nogen in man . More interestingly, the antibody response was demonstrated to
appear in young children, to be maximal in older patients, and showed a
parallelism with the prevalence and the intensity of the infection . This indicated
that the antibody response against the 38,000 Mr antigen could be considered
an important marker ofS . mansoni infection (4).
Although the 38,000 M,. antigen initially appeared as a good candidate for the
molecular cloning and subsequent studies, the glycanic nature of the epitope
recognized by the IPLSmI mAb limited its in vitro production by recombinant
DNA methodology . Secondly, the 38,000M r antigen was shown (5) to bind the
IPLSm3 mAb of IgG2c isotype capable of blocking both in vivo and in vitro
effector function(s) of the IPLSmI IgG2a mAb. We recently demonstrated (6)
the existence of similar blocking antibodies specific to the 38,000 Mr molecule
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in human infection and correlated the level of such blocking antibodies with the
presence or absence ofimmunity to reinfection.
The protective role of the 38,000 M, molecule and particularly the effect of
its IPLSm 1-defined epitope was also supported byan antiidiotypeantibody probe.
An antiidiotype antibody Ab2 produced against the IPLSml antibody (Abl)
elicits by immunization polyclonal Ab3 antibodies exhibiting specificity for the
38,000 M, antigen. Ab3 antibodies induce a significant level of eosinophil-
dependent cytotoxicity and passively transfer immunity. Most importantly, im-
munization with Ab2 led to a high degree ofresistance to a cercarial challenge
(7).
Recently, experiments performed on rats immunized with Ab2 mAb conju-
gated to KLH (currently used as a carrier in immunization with synthetic
peptides) led us to make some unexpected observations. We could show that rats
injected with KLH, used as control in the KLHfAb2 immunization, produced
anti-S. mansoni antibodies specific for the 38,000 M,. schistosomula surface
antigen. This observation was also supported by the demonstration that the
carbohydrate epitope of the 38,000 M, antigen that is present at the early life
cycle stages ofS. mansoni (miracidia) is also expressed by the intermediate host
Biomphalaria glabrata as well as by other freshwater snails (8).
In the present work, we provide new evidence for the existence of a shared
epitope between KLH and the 38,000 M, antigen, and that KLH immunization
elicits in rats the production of anti-S. mansoni antibodies with similar effector
functions to those induced during the course of infection. We have exploited
these latest results to investigate further the biological and immunological prop-
erties of this particular epitope.
Materials and Methods
Parasites.
￿
The Puerto Rican strain ofS. mansoni was used in all our experiments. The
parasite cycle was maintained in our laboratory with the use of B. glabrata snails as
invertebrate intermediate hosts and Golden hamsters, Mesocricetus auratus, as vertebrate
definitive hosts. Schistosomula of S. mansoni prepared according to the method of
Ramalho-Pinto et al. (9) and referred to as mechanically prepared schistosomula were
used throughout the work. For all the cytotoxicity assays, however, schistosomula were
prepared according to the skin penetration technique described by Clegg and Smithers
(10) and referred to as skin-transformed schistosomula.
Monoclonal Antibodies.
￿
IPLSml mAb is a purified anti-S. mansoni antibody of IgG2a
isotype (1). It was produced after fusion of spleen cells from rats infected with S. mansoni
for 5 wk and the nonsecretory IR983 F myeloma cell line (11). It was purified by DEAE
ion-exchange chromatography according to the method of Bazin et al. (12). For inhibition
experiments, purified IPLSml antibodies were radiolabeled with 125iodine by the chlora-
mine T method (13).
JM8-36 antibody is a rat antiidiotype mAb of IgM isotype specific for the IPLSml
antibody (7). Purified fractions ofJM8-36 were obtained by gel filtration chromatography
according to Bazin et al. (12).
Antigens and immunization procedure.
￿
Purified lyophilized KLH (mol wt, 3 x 106 to
7.5 x 106) was purchased from France Biochem. (Meudon, France). For inhibition
experiments, KLH was radiolabeled with 1211 by the chloramine T method (13). Degly-GRZYCH ET AL.
cosylation of KLH (DKLH)' was performed according to the procedure of Edge et al.
(14). Briefly, 5 mg of KLH was dissolved in I ml of anisole/trifluoromethanesulfonic acid
(TFMS) (I vol/2 vol) mixture and kept for 3 h at 0°C. The deglycosylated KLH was
freed of reagents and low molecular weight sugars by extraction with diethylether in the
presence ofaqueous pyridine followed by dialysis against pyridine acetate buffer, pH 5.5.
LOU/M rats (10 wk old, 180-200 g) were immunized twice at a 2 wk interval by
intraperitoneal injection of 1 ml of physiological saline solution containing 100 Ag KLH
or 100 Ag DKLH. Rats were bled every week from the start of the immunization. Sera
were recovered and stored at -20°C.
Indirect Immunofuorescence Assay.
￿
Anti-S. mansoni antibodies were detected by indi-
rect immunofluorescence on sections of S. mansoni schistosomula prepared as previously
described (9). Sections of 8 Am were overlayed with 50 Al of immunized rat sera at a
dilution of 1 :10 in 10 mM PBS buffer. After 30 min contact and three washings in PBS,
FITC-conjugated anti-rat Ig antisera prepared in rabbits (Miles Laboratories, Inc.,
Naperville, IL) were added for 30 min. The slides were then washed three times in PBS,
the last wash containing Evans Blue (1 :10,000 final dilution) as a counterstain. 4 wk
infected rat sera and normal rat sera (NRS) were used respectively as positive and negative
controls. The sections were examined under fluorescence microscopy.
Immunoprecipitation and Western Blotting Analysis.
￿
Schistosomula surface antigens were
ioiodinated using the lactoperoxidase technique of Marchalonis (15) and immunopre-
ated after incubation of the labeled parasite detergent extract (NP-40, 0.05%) with
rat antibodies. Immune complexes were adsorbed on protein A-Sepharose (Pharmacia
Fine Chemicals, Uppsala, Sweden) and analyzed by SDS-PAGE exactly as previously
described (16) .
KLH was analyzed in 10% polyacrylamide-SDS gels in the presence of 5% 2-ME (17),
then transferred onto nitrocellulose. Western blotting was performed according to the
method of Burnette (18) using 5,u] of rat sera or 10 tag of IPLSm 1 mAb. Fixed antibodies
were revealed by autoradiography after incubation with 5 X 105 cpm of '251-labeled rabbit
anti-rat IgG (8 X 10& cpm/,ug sp act).
Inhibition ofIPLSm]/KLH Binding.
￿
Inhibition experiments were carried out on poly-
vinylchloride (PVC) microtiter plates (Falcon Labware, Oxnard, CA) coated with IPLSm I
antibody. Each well of the PVC plates was coated with 100 Al of a 10 #g/ml solution of
purified IPLSmi antibody diluted with 10 mM PBS. After 2 h of incubation at 20°C, the
plates were washed twice in PBS and saturated for 30 min with 200 Al of a 2% BSA
(Albumin, Fraction IV; Boebringer Mannheim Biochemicals, Mannheim, Federal Repub-
lic of Germany) solution in PBS. The plates were then washed twice in PBS/0.1% BSA
(200 Al per well). For the test, 50 Al of 's5I-labeled KLH in PBS/0.1 % BSA (100,000
cpm/well) were incubated with 50 Al of inhibiting factor diluted in the same buffer for I
h at 37'C and 18 h at 4 °C. The plates were washed three times in PBS/0.1 % BSA and
each well was counted in a gamma counter. The percentage of inhibition of binding was
calculated using the following formula: 100 X (a - b)/a, where a is cpm obtained without
inhibitor and b is cpm obtained in the presence of inhibitor. In additional studies, PVC
plates were coated under the conditions described above with 100 ;al of a 10 pg/ml
solution of purified KLH in 10 mM PBS. 50 AI of
1251 IPLSmI antibody in PBS/0.1 %
BSA (100,000 cpm/well) were incubated with 50 Al of inhibiting factor diluted in the
same buffer. The experimental conditions of the assay and the evaluation of binding
inhibition were identical to those described above.
Inhibition of IPLSm1/38,000 Antigen Binding.
￿
Inhibition of binding of radiolabeled
IPLSmI antibody to 38,000 M, antigen was performed according to the technique
previously described (7). Briefly, PVC plates precoated with rat IgM C3-109 mAb
recognizing the 38,000 M, antigen, were incubated with 100 Al of a NP-40 extract of
schistosomula (100 teg protein/ml); this procedure allows a better fixation of the 38,000
867
'Abbreviations used in this paper:
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DKIRS, DKLH-immunized rat sera; DKLH, deglycosylated
KLH; IRS, infected rat sera; KIR, KLH immunized rat; KIRS, KLH-immunized rat sera, NRS,
normal rat sera; PVC, polyvinylchloride; TFMS, trifluoromethanesulfonic acid; TRI, synthetic
tripeptide (glycyl-histidyl-lysine).868
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A antigen . After 2 h of exposure at 37'C, plates were washed twice in PBS/0 .1% BSA .
For the inhibition test, 50 A1 of `251-labeled IPLSm1 in PBS/0.1% BSA were incubated
with 50 Al of inhibiting factor . After 2 h at 37°C and 18 h at 4°C, plates were washed
three times with PBS/0.1% BSA (100 Al/ml) and the wells were counted in a gamma
counter . The percentage of inhibition was calculated according to the formula previously
defined .
Inhibition of Radiolabeled IPLSmI Binding to KLH by Sera from Infected Patients .
Inhibition experiments were performed on PVC microtiter plates precoated with KLH .
Sera were obtained from untreated patients in an endemic area in Kenya and selected on
the basis of egg counts. They were kindly donated by Dr . A . E . Butterworth, (Cambridge
University, United Kingdom) . Normal human sera were obtained from subjects without
any parasitic infection . For the test, 50 Al of "'I-labeled IPLSmI were incubated I h at
37 °C and 16 h at 4°C with 50 Al of diluted infected or normal sera (dilution 1 :50 in
PBS/0 .1% BSA) . Plates were then washed three times in PBS/0.1% BSA and wells were
counted in a gamma counter . The percentage of inhibition was measured according to
the formula defined above .
Eosinophil-dependent Cytotoxicity .
￿
The cytotoxicity assays were performed onS . mansoni
skin schistosomula, as previously described by Capron et al . (19) . Briefly, effector cells
were obtained from LOU rats stimulated 48 h previously by intraperitoneal injection of
10ml 0.9% NaCl sterile physiological saline solution ; peritoneal cavities were washed with
20 ml Eagle's MEM containing penicillin (100 U/ml), streptomycin (50 U/ml), I% NRS,
20 ng/ml synthetic tripeptide (glycyl-histidyl-lysine [TRI], Calbiochem-Behring Corp .,
San Diego, CA) and 25 IU/ml calcium heparinate (MEM/NRS/TRI) . Eosinophil-rich
populations were prepared by allowing these peritoneal cells (5-7 x 106/ml in
MEM/NRS/TRI) to adhere for 2 h at 37°C in 25-cm' tissue culture flask (Corning Glass
Works, Corning, NY) . The nonadherent cells of each tissue culture flask were recovered,
pooled, and washed twice in MEM/NRS/TRI . After staining with Discombe's diluent or
toluidine blue, this cell population was shown to contain 40-90% eosinophils and 4-10%
mast cells . The cytotoxic assay was carried out in sterile plastic microplates with flat-
bottomed wells (Nunclon, Roskilde, Denmark). 50 schistosomula were added to each well
and incubated overnight with 50 Al of KLH-immunized rat sera (KIRS), DKLH-immu-
nized rat sera (DKIRS), or 50 Al NRS or infected rat serum (IRS) at a final dilution of
1 :16 (sera were previously heat-inactivated for 2 h at 56°C) . After 18 h incubation,at
37°C, effector cells were added in a 100 Al ofMEM/NRS/TRI at a ratio of 6,000 effector
cells for one schistosomulum . The plates containing effector cells and sensitized targets
were incubated in a 5% C02 humidified atmosphere at 37°C . The percentage of
cytotoxicity was measured after 24-48 h by microscopic examination .
Passive Transfer Experiments .
￿
2 ml of sera from rats immunized with KLH (KIRS)
were injected intravenously into male LOU rats (10 wk old, 180-200 g) that had been
infected with 800 S . mansoni cercariae 4 h previously . Parasite burdens were evaluated 3
wk later by the liver-perfusion technique according to Smithers and, Terry (20) . The
number of worms obtained from rats injected with KIRS were compared with those
obtained from control groups (rats injected with 2 ml of physiological saline solution or 2
ml ofNRS) . The percentage of protection was calculated by the formula (21) : 100 x (a
- b)/a, where a is the number of worms recovered from rats injected with 2 ml of
physiological saline solution and b is the number ofworms recovered from rats injected
with KIRS .
Active Immunization .
￿
For active immunization experiments, male LOU M rats (10 wk
old, 180-200 g) were immunized twice at 2 wk intervals by intraperitoneal injection of 1
ml of physiological saline solution containing 100 Ag of KLH . 3 wk after the second
injection, rats were infected with 800 S . mansoni cercariae . The worm recovery and the
evaluation of the percentage of protection were performed as described above, 3 wk after
the cercarial challenge . In these experiments, rats injected with I ml of physiological
saline solution were used as negative controls.GRZYCH ET AL .
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FIGURE 1 .
￿
Epitopic identity between S . mansoni38,000 M, antigen and KLH. (A) "5I-labeled
schistosomula surface antigens were immunoprecipitated by 10,uI of NRS, IRS, KIRS, or 10
jag of purified IPLSml mAb . (B) KLH-purified preparation was analyzed in a 10% SDS-
polyacrylamide gel under reducing conditions and then transferred to nitrocellulose. Immu-
nodetection was performed with 5 uI of NRS, 5 tal IRS, 5 jul of KIRS, or 10 jig of purified
IPLSml antibody.M, X 10-s are shown .
Results
Antigenic Community between KLH and the 38,000 M, Antigen .
￿
The existence
ofacommon antigenic structure shared byKLH and S. mansoni was investigated
by immunoprecipitation and Western blotting methodologies. Immunoprecipi-
tation of radiolabeled schistosomulum antigen (Fig. 1 A) showed that sera from
rats immunized with KLH recognize a 38,000 M, antigen present on the
schistosomulum surface andpreviously demonstrated as the target antigen of the
IPLSml-protective mAb (2) . Additionally, the analysis ofa purified fraction of
KLH by SDS-PAGE under reducing conditions (Fig . 1B) revealed by Western
blotting that IPLSm 1 mAbandinfected rat sera recognize inKLH twomolecules
of ^-150-200 X 103 mol wt .
Inhibition ofIPLSml Binding toKLH .
￿
Binding of 121I-labeled IPLSm l toKLH
coated on PVC plates was shown to be strongly inhibited in a dose-dependent
manner by various concentrations of unlabeled IPLSml . Similar levels of inhi-
bition could be obtained in the presence ofS . mansoni-infected rat sera (Fig . 2) .
Epitopic Community.
￿
The structural identity between KLH and the 38,000 M,
antigen epitope defined by the IPLSml mAb was further studied in inhibition
experiments performed in the presence of the JM8-36 antiidiotype antibody
specific for IPLSml antibody . Results in Fig. 3A show that JM8-36 antibody87 0
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FIGURE 2 . Dose-dependent inhibition of IPLSml/KLH binding. 50 ul of 1251-labeled
IPLSml antibody were incubated with 50 Al of various concentrations of unlabeled IPLSml,
50 ul of 4wk IRS, or 50 ul ofNRS .
FIGURE 3 .
￿
Inhibition of IPLSml/KLH binding by JM8-36 antiidiotype antibody . (A) 50 ul
of 1251-labeled KLH were incubated with 50 ul of a solution containing either 50 ug of KLH,
IPLSml antibody, JM8-36 antiidiotype antibody or unrelated IgM, on plates coated with
purified IPLSml antibody . (B) 50 ul of 1251-labeled IPLSml were incubated with 50 ul of the
same solutions on plates coated with native KLH.
inhibits the binding of '251-labeled KLH to IPLSml antibody coated on PVC
plates at a level comparable to that obtained either with unlabeled KLH or with
purified IPLSm I antibody . Moreover, JM8-36 antiidiotype antibody can also
inhibit ' 251-labeled IPLSml binding to KLH coated on PVC plates at a levelGRZYCH ET AL .
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FIGURE 4 .
￿
Inhibition of "5I-IPLSml binding to the 38,000 M, antigen . (A) 50 JAI of various
concentrations of native KLH or DKLH were incubated with 50 1I of '25I-labeled IPLSml
mAb (100,000 cpm/well) . (B) 50 wl of 1 :50 diluted sera collected from KIRS, DKLH
immunized rats, 4 wk IRS, NRS, or IPLSml ascitic fluid were incubated with 50 Pl of
1251_
labeled IPLSml antibody (105 cpm/well) .
comparable to that seen with unlabeled IPLSm 1 or KLH . These results therefore
suggest a close structural identity between the antigenic determinant of KLH,
the internal image of the antigen expressed on JM8-36 antiidiotype antibody,
and the 38,000 M, antigen epitope defined by the IPLSml mAb .
Involvement of Carbohydrate Moieties . The previous demonstration that
IPLSm 1 mAb binds to the 38,000 M, . antigen via a glycanic epitope (2) led us to
compare the immunological properties ofnativeand deglycosylated KLH . Native
KLH preparations used at various concentrations inhibit the binding of 1211_
labeled IPLSml to its 38,000 M,. target antigen . This activity is completely
abolished when KLH is deglycosylated by TFMS treatment (Fig . 4A) . Addition-
ally, a marked inhibition of binding of ' 21I-labeled IPLSml could be induced
with KIRS or IRS, but not with the sera from rats immunized with DKLH or
NRS (Fig. 4B) .
Eosinophil-dependent Cytotoxicity . The relationship between the existence of
antibody-mediated eosinophil-dependent cytotoxicity for schistosomula and the
38,000M, antigen prompted us to investigate the presence ofcytotoxic antibodies
in the sera collected from rats immunized with KLH . The cytotoxic activity of
anti-KLH rat sera was investigated in the presence ofnormal rat eosinophils . In
these particular conditions, anti-KLH rat sera were shown to exhibit a marked
killing activity towards S . mansoni skin schistosomula ranging between 46 and
94% and comparable to that usually obtained using 4 wk-IRS (19) or the
protective mAb IPLSml . No cytotoxicity was observed with sera collected from
rats immunized with DKLH (Fig . 5) .
Passively Transferred Immunity .
￿
The potential protective role ofanti-KLH rat
sera was investigated by passive transfer experiments in naive LOU rats . The872
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FIGURE 5.
￿
Eosinophil-dependent cytotoxicity forS . mansoni schistosomula . The percentage
of cytotoxicity was measured after 48 h of incubation with effector cells(LOU rat peritoneal
cells enriched in eosinophils) ; schistosomula were preincubated either with KIRS, DKIRS, 4
wk IRS, NRS, or IPLSmI mAb(mean of 10 duplicate experiments t SD).
parasite burden was evaluated by liver perfusion 3 wk after a challenge infection
with 800 S. mansoni cercariae . Results presented in Fig . 6A indicated that
antibodies produced in KLH-immunized rats passively transferred immunity to
a degree (48%) very close to that previously observed for the IPLSmI mAb . In
these experiments, rats receiving KIRS presented a lower number of worms
when compared with rats treated with NRS or physiological saline solution (Fi
6A) .
Active Immunization.
￿
The protective effect of immunization with KLH was
studied in naive LOU rats immunized twice at 2 wk intervals with 100 jug of
KLH and infected 3 wk after the second injection by 800 S. mansoni cercariae .
The effectiveness of the procedure was evaluated 3 wk after the challenge
infection by liver perfusion . Two series of experiments involving a total of 24
rats demonstrated that rats previously immunized with KLH presented a signif-
icant decrease in the parasite burden when compared with appropriate controls
(rats treated with physiological saline solution) . The level of protection obtained
in these experiments ranged between 50 and 70% (Fig . 6B) .
Studies on SerafromHumans Infected with S. mansoni.
￿
Previous studies (4)have
demonstrated that the 38,000 Mr antigen glycoprotein is a major immunogen in
human infection and induced the production of specific antibodies in 97% of S.
mansoni-infected patients . The potential use ofKLH for the detection of anti-
S . mansoni antibodies in human sera was explored using a competitive RIA withGRZYCH ET AL.
FIGURE 6 .
￿
In vivo protective role of anti-KLH antibodies. (A) 1 .5 ml of KIRS, 1.5 ml of
NRS, or 1 .5 ml of physiological saline solution were injected intravenously into each rat
(groups of six animals in each test) that had been infected 4 hpreviously with 800 S. mansoni
cercariae . (B) KIR or rats injected with physiological saline solution (C) were infected with
800 S. mansoni cercariae . In A and B, the number of worms was estimatedby liver perfusion
21 d after the challenge infection .
TABLE I
Inhibition of"I IPLSml Binding to KLH byHuman Serum
Human sera source
Discussion
Percent inhibition
±SD
S . mansoni-infected human sera (n = 20)
￿
68 t 13 .3
Normal human sera (n = 20)
￿
0.5 f 1 .1
50
Al of 12'1-labeled IPLSml (105 cpm/well) were incubated on plates
coated with KLH for 1 hat 37°C, and for 16 h at 4 C with 50 Al of 1 :50
diluted infected or normal sera .
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PVC plates coated with KLH. Results summarized in Table I and concerning a
limited series of human infection sera show that the latter significantly inhibit
the binding of radiolabeled IPLSml antibody to KLH (68 ± 13.3%) . No
significant levels of inhibition were observed with the various control sera (0.5
± 1.1%) .
The experimental data reported here clearly demonstrate that the immuniza-
tion of naive LOU rat with purified hemocyanin of Megathura crenulata (KLH)
elicits the production of specific anti-S. mansoni antibodies exhibiting both in
vitro and in vivo effector functions towards S . mansoni schistosomula, indicating
therefore the presence of a functional crossreactive epitope between KLH and
the 38,000 M, antigen .
These observations found a molecular basis in the demonstration that sera874
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collected from KLH-immunized rats contain antibodies able to immunoprecipi-
tate from a schistosomula extract the 38,000 M,. surface antigen previously
reported as the target antigen of the protective IPLSml mAb and of antibodies
from human or experimental infection sera. The antigenic similarity was con-
firmed by Western blotting analysis of KLH in which two molecules of about
150,000 and 200,000 Mr were recognized both by IPLSml mAb antibody or S.
mansoni-infected rat sera.
The existence of a shared epitope between KLH and the 38,000 Mr antigen
was fully supported by the results obtained in inhibition experiments performed
using the JM8-36 antiidiotype antibody. The latter induced both a marked
inhibition ofbinding of '251-labeled KLH to IPLSml antibody or of 121I-labeled
IPLSml to KLH, suggesting therefore a close structural identity between the
epitope ofKLH, of the 38,000 M, antigen and the internal image of the 38,000
Mr epitope presented by theJM8-36 antiidiotype antibody.
The glycanic nature of the portion of the KLH molecule recognized by the
IPLSml antibody was established by further inhibition experiments. Deglycosy-
lation of the native KLH by TFMS treatment abolished the inhibitory effect of
KLH on the binding of labeled IPLSml to its target antigen. On the other hand,
sera collected from rats immunized with DKLH were completely devoid of
inhibitory activity on IPLSml/38,000 M, antigen binding when compared with
the sera obtained from rats immunized with native KLH, or rats infected with
S. mansoni. These results confirmed the close structural and chemical identity
between KLH and the 38,000 M, antigen previously demonstrated to bind the
IPLSml mAb through a glycanic epitope.
The functional properties of the carbohydrate epitope present on native KLH
molecules were studied in the light of the relationship previously reported
between killing of schistosomula mediated by normal rat eosinophils and the
38,000 M schistosomula surface antigen (1). A marked level of eosinophil-
dependent cytotoxicity was observed in the presence ofseracollected from KLH-
immunized rats, comparable to that obtained with IRS or IPLSml mAb; no
cytotoxicity was observed with the sera from rats immunized with DKLH. These
results indicated that, together with a structural identity between KLH and
38,000 M, carbohydrate moieties, the KLH epitope recognized by IPLSml
antibodies expressed similar immunological functions and elicited by immuniza-
tion the production ofcytotoxic antibodies. The effector functions of anti-KLH
antibodies were also confirmed in vivo by passive transfer experiments. Sera
collected from rats immunized with KLH were found to be protective, when
passively transferred to rats, to a degree similar to that induced by the IPLSml
antibody. More importantly, the prior immunization of naive LOU rats with
purified KLH gave a high level of protection towards a subsequent S. mansoni
challenge. The parasite burden estimated by liver perfusion methodology was
significantly reduced when compared with appropriate controls.
These latest data increase the interest for the well-defined characterization
and isolation of this glycanic epitope shared both by KLH molecules and the
38,000 M, schistosomula surface antigen, and potentially available for an im-
munoprophylactic approach towards schistosomiasis. From these encouraging
results, observations in various experimental infection models and particularlyGRZYCH ET AL.
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in primates to evaluate the immune response against this glycanic epitope should
follow.
In man, preliminary investigation performed using a competitive RIA allows
the characterization ofspecificantibodies that can inhibit the binding ofIPLSmI
antibody to KLH in the sera of S. mansoni-infected patients. Although the
existence of natural antibodies to KLH in some individuals has been reported
(22), no significant level ofinhibition was observed with the various control sera
used. The fact that almost all subjects infected by S. mansoni produce antibodies
against the glycanic epitope ofthe 38,000 Mr antigen also present in KLH opens
an entirely new pathway towardsthe development ofasimple, easily standardized
and cheap reagent for the seroepidemiology of human schistosomiasis. We are
at present applying this methodology to a large series ofwell-documented sera.
This paper brings new evidence that the carbohydrate moieties of Megathura
crenulata hemocyanin (KLH) express the epitope previously characterized on a
major immunogen 38,000 M,. antigen of the parasite S. mansoni and clearly
demonstrate its capacity to elicit by immunization the production of functional
antibodies both in vitro and in vivo. Such observations appear to have several
major consequences.
The close structural and functional identity between KLH carbohydrate moie-
ties and the glycanic epitopeofthe 38,000 M,.antigen providesnew opportunities
to analyze further in man and animal models the isotypes induced towards a
potentially protective epitope. KLH could represent in this context a valuable
tool for the identification of the human antibody isotype(s) directly involved in
the eosinophil-mediated killing of schistosomula.
The characterization on the KLH molecule ofa functional epitope recognized
by theprotective IPLSm1 mAb offers newopportunities to purify a large amount
ofthe oligosaccharide for the study ofits chemical structure. Our current work
using mass spectroscopy analysis of the purified KLH oligosaccharides renders
access to a well-defined structure feasible in the near future, a first step in the
production of synthetic oligosaccharides. Such material could certainly provide
essential information concerning the potential relations existing between the
chemical nature ofa functional epitope and the preferential induction ofspecific
antibody isotype(s). This latest point appears to be essential since we previously
demonstrated in schistosomiasis the production of blocking mAbs towards the
38,000 M,. glycoprotein antigen. Two ways ofinvestigation could be proposed at
this stage, either a slight modification of the initial chemical structure of KLH
carbohydrate moieties involved in the production offunctional antibodies or the
production of neoglycoproteins obtained by a chemical condensation of KLH
oligosaccharides withvarious carrier proteins. Theseexperiments could certainly
lead to the appreciation of the real role played by the carrier proteic structure
in the orientation of the immune response towards a specific epitope. In this
context, we plan to apply such an approach to the P28 antigen of S. mansoni
recently described (23) as promoting a protective immune response in rats and
mice against S. mansoni infections.
Moreover, our findings have to be consideredin the general frameworkofthe
antigenic community existing between parasites and their hosts. This concept
established in our laboratory some 20 yr ago indicates that some antigenic876
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determinants were present both on S. mansoni and its snail intermediate host B.
glabrata (24) and elicited the production of antibodies appearing early during
experimental or human infection (25). These results, confirmed in several
laboratories (26-30), were recently updated by the demonstration that the
glycanic epitope of the 38,000 MT glycoprotein that is a major immunogen of S.
mansoni schistosomula is in fact expressed by the intermediate host B. glabrata
and several freshwater and marine molluscs (8) . Such observations raised the
problem of the conservation of this oligosaccharide structure throughout evolu-
tion and the expression in a human parasite of a major antigenic epitope whose
origin was found in a marine mollusc Megathura crenulata that has been in
existence for several million years.
Finally, it will certainly be of interest to immunologists, who have used KLH
for the last 20 yr as a carrier for the immunization of humans or animals, to
know that it can lead to the production of anti-S. mansoni antibodies.
Summary
The glycanic epitope of the 38,000 Mr Schistosoma mansoni schistosomula
major immunogen defined by the IPLSmI protective mAb was identified in the
hemocyanin of the marine mollusc Megathura crenulata, better known as KLH.
This antigenic community was exploited to investigate further the biological
properties of this epitope. KLH was shown to strongly inhibit the binding of
IPLSm 1 mAb to its 38,000 Mr target antigen. Immunization of naive LOU rats
with KLH elicited the production of anti-S. mansoni antibodies capable of
immunoprecipitating the 38,000 Mr schistosomulum antigen. Antibodies to KLH
mediated a marked eosinophil-dependent cytotoxicity and passively transferred
immunity towards S. mansoni infection. Finally, rats immunized with KLH were
significantly protected against a challenge with S. mansoni cercariae.
The deglycosylation of KLH completely abolishes its immunological and
functional KLH properties, indicating the participation of an oligosaccharidic
epitope of the native KLH that is also recognized by the sera of S. mansoni-
infected patients.
These observations provide new opportunities of access to the well-defined
structure of a glycanic epitope potentially available for the immunoprophylaxis
and seroepiderniology of schistosomiasis, and a new approach to the isotypic
response towards a well-chemically defined epitope.
The authors thank Dr. A. E. Butterworth for access to sera from S. mansoni-infected
patients and Dr. R. J. Pierce for helpful advice. The expert assistance of A. Caron andJ .
Trolet was greatly appreciated, as well as the help of C. Colson and M. F. Massard in the
preparation ofthe manuscript.
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